Orchid raw stock: Lift a ban difficult hindrance share price takes dance

Sea coherent bond( love share, quotations, information) Zhang Qi

Yesterday, orchid raw stock( love share, quotations, information) announcement, the company's limited circulation stock sold condition 14.02141 million will circulate on the market from January 21( next Monday).

Comment: Orchid raw stock is Shanghai famous foreign trade appears on the market enterprise, the situation in recent years of foreign trade is serious, company's main business is all right before bearing a heavy burden. Though as main business, but, company has some bright spots.

One is that company now holds 101 million sea coherent bonds, according to the Tuesday shelf calculation of closing price, the about 5800 million Yuan of market value is equivalent to each 20.7 Yuan and the market price of orchid raw stock now to match basically. See from all previous financial report before the 3 quarterly reports of last year, company enters this part of stock right according to investment cost idea " long-term stock right investment " subject, though this part of stock right will wait November 2010 to appear on the market , but so as each sum until the price of 2.8 Yuan Zhang have covered company really to hold the true value of stock right. According to the condition that the author knows , in the 2007 annual reports that will soon reveal , this kind of condition will get correction, company's each net asset may have a huge increase.

2 is that company holds the Shanghai orchid raw country stock right of healthy medicine field company's 34.65%, and orchid raw country is healthy with the letter in Hong Kong safe rich common investment sets up " the letter country healthy medicine field limited company in Shanghai", in which, orchid raw country is healthy to take the 49% of registered capital. The benefit match of orchid raw country healthy production general is the good medicine of treatment rheumatoid arthritis, recently, get " the 2007 national invention awards of science and technology second class award ", last year, total sale exceeds 150 million Yuan, the rate of gross profit is very high. Now, the gladly beautiful shelf that company's treatment blood platelet reduces has still had many new medicines on the market, besides to enter clinical experiment or is steping up to research and develop , probably for company's long term profit add bright color.

The 14.02 million limits that orchid raw group holds recently sell share will soon lift a ban , say theoretically can increase the stock supply of market, but orchid raw stock share price contrary wind rises to rise considerably, have reflected the true expectation of investor for company's value.